Biomedical Engineering Reference
In-Depth Information
23. Silbaugh SA, Stengel PW, Cockerham SL, Froelich LL, Bendele AM, Spaethe
SM, et al. Pharmacologic actions of the second generation leukotriene B
4
receptor antagonist LY29311: in vivo pulmonary studies. Naunyn Schmiede-
bergs Arch Pharmacol 2000; 361:397-404.
24. Crooks SW, Bayley DL, Hill SL, Stockley RA. Bronchial inflammation in
acute bacterial exacerbations of chronic bronchitis: the role of leukotriene
B
4
. Eur Respir J 2000; 15:274-280.
25. Lee E, Robertson T, Smith J, Kilfeather S. Leukotriene receptor antagonists
and synthesis inhibitors reverse survival in eosinophils of asthmatic indivi-
duals. Am J Respir Crit Care Med 2000; 161:1881-1886.
26. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma.
J Allergy Clin Immunol 2002; 109:615-620.
27. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Incre-
ased leukotrienes in exhaled breath condensate in childhood asthma. Am J
Respir Crit Care Med 2002; 166:1345-1349.
28. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1997; 156:341-357.
29. Macnee W. Oxidative stress and lung inflammation in airways disease. Eur J
Pharmacol 2001; 429:195-207.
30. Dekhuijzen PNR, Aben KHH, Dekker I, Aarts LPHJ, Wielders PLM, van
Herwarden CLA, et al. Increased exhalation of hydrogen peroxide in patients
with stable and unstable chronic obstructive pulmonary disease. Am J Respir
Crit Care Med 1996; 154:813-816.
31. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov
SA, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative
stress in patients with COPD and healthy smokers. Am J Respir Crit Care
Med 2000; 162:1175-1177.
32. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled
ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pul-
monary disease. Am J Respir Crit Care Med 2000; 162:369-373.
33. Rhoden KJ, Barnes PJ. Effect of oxygen-derived free radicals on responses of
guinea-pig tracheal smooth muscle in vitro. Br J Pharmacol 1989; 98:325-330.
34. Lei Y-H, Barnes PJ, Rogers DF. Involvement of hydroxyl radicals in neuro-
genic airway plasma exudation and bronchoconstriction in guinea pigs in vivo.
Br J Pharmacol 1996; 117:449-454.
35. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reac-
tive nitrogen species production in chronic obstructive pulmonary disease
airways. Am J Resp Crit Care Med 2000; 160:701-706.
36. Maestrelli P, Paska A, Saetta M, Turato G, Nowicki Y, Monti S, et al.
Decreased haem oxygenase-1 and increased inducible nitric oxide synthase
in the lung of severe COPD patients. Eur Respir J 2003; 21:971-976.
37. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ.
Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir
Crit Care Med 1998; 157:998-1002.
38. Rutgers SR, Van der Mark TW, Coers W, Moshage H, Timens W, Kauffman
HF, et al. Markers of nitric oxide metabolism in sputum and exhaled air are
